Replies to post #92143 on Biotech Values

[iwfal]

ONCY -

a recent finding that this virus can kill prostate cancer cells. These are Canadian researchers and they are only entering phase I trial. This could have major implications for not only companies like DNDN but other oncology companies as well.

Regarding "major implications" - in the long run perhaps. But my impression, having casually tracked them for a while, is that they are somewhat wandering in the woods. Some of that is due to the unique nature of their treatment (so they have to explore a large number of different paths) - but some appears to be just their style. So I wouldn't expect anything to happen quickly.